FIRINU, DAVIDE
 Distribuzione geografica
Continente #
EU - Europa 205.835
NA - Nord America 6.125
AS - Asia 1.324
AF - Africa 30
SA - Sud America 28
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 213.361
Nazione #
IT - Italia 204.080
US - Stati Uniti d'America 6.066
CN - Cina 701
SE - Svezia 526
UA - Ucraina 415
SG - Singapore 287
DE - Germania 214
FI - Finlandia 178
GB - Regno Unito 162
VN - Vietnam 102
FR - Francia 81
CA - Canada 51
KR - Corea 48
TR - Turchia 38
HK - Hong Kong 32
NL - Olanda 32
IN - India 26
BE - Belgio 21
IR - Iran 21
IE - Irlanda 18
ES - Italia 17
RU - Federazione Russa 16
ID - Indonesia 14
AU - Australia 13
CO - Colombia 11
IL - Israele 9
PT - Portogallo 9
CZ - Repubblica Ceca 8
JP - Giappone 8
ZA - Sudafrica 8
BR - Brasile 7
MY - Malesia 7
TW - Taiwan 7
AT - Austria 5
CH - Svizzera 5
CL - Cile 5
DK - Danimarca 5
HU - Ungheria 5
MK - Macedonia 5
MX - Messico 5
NG - Nigeria 5
PH - Filippine 5
RO - Romania 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
EU - Europa 4
IQ - Iraq 4
LT - Lituania 4
HR - Croazia 3
KE - Kenya 3
NO - Norvegia 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
DZ - Algeria 2
GR - Grecia 2
KW - Kuwait 2
LU - Lussemburgo 2
LY - Libia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PL - Polonia 2
PR - Porto Rico 2
RS - Serbia 2
SD - Sudan 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
BD - Bangladesh 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
IS - Islanda 1
LB - Libano 1
LK - Sri Lanka 1
MT - Malta 1
PK - Pakistan 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 213.361
Città #
Cagliari 198.096
Uta 5.077
Fairfield 799
Woodbridge 559
Chandler 534
Boardman 509
Ashburn 460
Houston 454
Nyköping 405
Wilmington 323
Seattle 275
Cambridge 251
Ann Arbor 246
Jacksonville 204
Singapore 167
Shanghai 150
Helsinki 121
Dearborn 110
Dong Ket 102
Beijing 101
Boston 90
Nanjing 82
New York 80
Rome 69
San Diego 69
Redwood City 62
Milan 57
Los Angeles 43
Guangzhou 38
Seoul 34
Toronto 34
Nanchang 31
London 29
Washington 28
Verona 27
Changsha 26
Hong Kong 26
Jiaxing 25
Shenyang 24
Kocaeli 21
Monserrato 21
Mountain View 19
Sassari 19
Norwalk 18
Redmond 17
Brussels 16
Zhengzhou 16
Bari 15
Hebei 14
Paris 14
Tianjin 14
Turin 14
Wuhan 14
Vicenza 12
Jinan 11
Orange 11
Sestu 11
Chicago 10
Jakarta 10
Phoenix 10
Rheinfelden 10
Shenzhen 10
Amsterdam 9
Florence 9
Frankfurt am Main 9
Munich 9
Naples 9
Quartu Sant'Elena 9
Auburn Hills 8
Gyeongsan-si 8
Hangzhou 8
Leawood 8
Ningbo 8
Palermo 8
Romainville 8
San Mateo 8
Augusta 7
Bogazici 7
Borås 7
Brno 7
Dublin 7
Chennai 6
Pune 6
Quartu Sant'elena 6
Andover 5
Atlanta 5
Columbus 5
Cork 5
La Spezia 5
Ploaghe 5
Salerno 5
Seregno 5
Tortolì 5
Truccazzano 5
Vienna 5
Wuxi 5
Abidjan 4
Bogotá 4
Brent 4
Brooklyn 4
Totale 210.391
Nome #
Comparing the responses of countries and National Health Systems to the COVID-19 pandemic: a critical analysis with a case-report series 20.493
TH17 cells are increased in the peripheral blood of patients with SAPHO syndrome 3.878
Overexpression of the cytokine BAFF and autoimmunity risk 3.876
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 3.742
The salivary proteome profile in patients affected by SAPHO syndrome characterized by a top-down RP-HPLC-ESI-MS platform 3.709
Systemic lupus erythematosus occurring in a patient with Niemann-Pick type B disease. 3.378
Gastrointestinal Coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management 3.093
Zinc status and autoimmunity: A systematic review and meta-analysis 2.897
The Salivary Proteome Profile in Patients Affected by SAPHO Syndrome characterized by a top-down RP-HPLC-ESI-MS platform 2.882
Characterization of patients with angioedema without wheals: The importance of F12 gene screening 2.625
Alteration of the salivary secretory proteome profile in adults affected by antibody deficiency diseases 2.601
Fungal allergy in asthma 2.601
Exercise-induced anaphylaxis with an Ayurvedic drug as cofactor: A case report 2.600
Proteomic Analysis of the Acid-Insoluble Fraction of Whole Saliva from Patients Affected by Different Forms of Non-histaminergic Angioedema 2.578
SAPHO Syndrome: Current developments and approaches to clinical treatment 2.560
Top-Down Proteomics of Human Saliva Discloses Significant Variations of the Protein Profile in Patients with Mastocytosis 2.494
COVID-19 in the mediterranean area: Epidemiology and main disease characteristics - A narrative review 2.490
RP-HPLC-ESI-IT Mass Spectrometry Reveals Significant Variations of the Human Salivary Protein Profile Associated with Predominantly Antibody Deficiencies 2.446
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 2.405
Biological treatments for SAPHO syndrome: an update 2.329
Impaired endothelial function in hereditary angioedema during the symptom-free period 2.273
Evaluation of olfactory function as a potential biomarker in patients with Mastocytosis 2.252
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 2.184
Oxidative stress markers in patients with hereditary angioedema 2.177
Baricitinib exposure during pregnancy in rheumatoid arthritis 2.156
Alteration of the Salivary Secretory Proteome Profile in Adults Affected by Immune Deficiency Diseases 2.147
Increased peripheral T(H)17 Cells in SAPHO syndrome: a novel target for treatment? 2.095
Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie = Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic 2.094
Biologics for ANCA-associated vasculitis 2.087
Genetic variants regulating immune cell levels in health and disease 2.006
Seroprevalence of SARS-CoV-2 in unselected surgical patients: An update from an unicentric regional study 1.984
An uncommon cause of refractory pleural effusion in an elderly patient 1.911
Periodic fever syndromes and autoinflammatory diseases: a case series from an Italian centre 1.884
Clinical pitfalls of leishmaniasis and Whipple’s disease hidden behind systemic lupus erythematosus: A case series 1.876
The role of genetics in the current diagnostic workup of idiopathic non-histaminergic angioedema 1.833
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 1.814
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 1.793
Vaping effects on asthma: results from a web survey and clinical investigation 1.772
Is the Inversion in the Trend of the Lethality of the COVID-19 in the Two Hemispheres due to the Difference in Seasons and Weather? 1.744
Mutation of angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema 1.720
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma 1.675
Asthma and psychiatric disorders 1.662
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 1.639
Relevance of essential trace elements in nutrition and drinking water for human health and autoimmune disease risk 1.618
Genetic factors associated with levels of immune cell types 1.603
The climate in the European Union and the enlarged European Region is a determinant of the COVID-19 case fatality ratio 1.546
Influenza burden, prevention and treatment in asthma - a scoping review by the EAACI Influenza in Asthma Task Force 1.514
Exercise and asthma: an overview 1.500
The Effect of Exposure to SARS-CoV-2 Vaccination and Infection on Humoral and Cellular Immunity in a Cohort of Patients with Immune-Mediated Diseases: A Pilot Study 1.491
Successful Treatment of Chronic Mucocutaneous Candidiasis Caused by Azole-Resistant Candida albicans with Posaconazole 1.490
EAACI Biologicals Guidelines—Recommendations for severe asthma 1.490
Granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency: a case report 1.467
Seroprevalence of SARS-Cov-2 in the setting of a non-dedicated COVID-19 hospital in a low CoV-2 incidence area: Implications for surgery 1.467
Is hereditary angioedema related to an increased risk of atherosclerosis? 1.430
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma 1.413
Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype 1.403
Management of Intermittent and Persistent Asthma in Adolescent and High School Athletes 1.387
Hyperosinophilia and recurrent angioedema in a patient with giant cell arteritis: a diagnostic "glitch" in a case of Gleich's syndrome 1.380
The COVID-19 incidence in Italian regions correlates with low temperature, mobility and PM10 pollution but lethality only with low temperature 1.350
A Beacon in the Dark: Canakinumab. A New Therapeutic Perspective in Chronic Tophaceous Gout 1.344
Identification of a novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema 1.311
Celiac disease: peripheral blood cell-mediated response to antigen-specific stimulation 1.307
Biologics for SAPHO syndrome: a single centre experience 1.297
Exercise training, lymphocyte subsets and their cytokines production: experience of an Italian professional football team and their impact on allergy 1.272
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 1.247
Eosinophilic granulomatosis with polyangiitis relapse after covid-19 vaccination: A case report 1.211
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 1.208
An uncommon association of antiphospholipid syndrome, selective IgA deficiency and resistant-to-treatment relapsing polychondritis: efficacy of Infliximab 1.150
Urticaria and angioedema as possible misleading skin symptoms in families with hereditary angioedema 1.148
Melkersson-Rosenthal Syndrome: A case report 1.145
Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor 1.127
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination 1.126
Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination 1.109
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype 1.084
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma 1.074
Idiopathic pyoderma gangrenosum: Successful resolution with Infliximab therapy and proinflammatory cytokines assessment 1.067
Angioedema without wheals: a retrospective analysis of a single center cohort 1.059
Metabolomics, microbiota, and in vivo and in vitro biomarkers in type 2 severe asthma: A perspective review 1.059
Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor 1.049
COVID-19 Case Fatality Ratio of Latino America Countries with Temperate Climate Partially Follows European and Oceania Trends According to Seasonal Change 1.049
Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination 1.045
Olfactory Function Is Impaired in Patients with Mastocytosis 1.036
Raynaud's phenomenon and scleroderma associated with silicone gel breast implants: An example of Asia syndrome 1.035
Systemic reactive (AA) amyloidosis in the course of common variable immunodeficiency 1.004
Oxidative stress in hereditary angioedema caused by C1 inhibitor deficiency: An interesting finding that deserves further studies 991
Adult antibody deficiency syndrome and Henoch-Schoenlein Purpura: a report of two cases 961
A promising new treatment for SAPHO syndrome that deserves further studies 930
Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: A case report 921
Eosinophil Cationic Protein Variation in Patients with Asthma and CRSwNP Treated with Dupilumab 876
A Novel Mutation in the SERPING1 Gene in Patients with Hereditary Angioedema and a Coexistent Complement Deficiency 864
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 859
Previous functional social and behavioral rhythms affect resilience to COVID-19-related stress among old adults 857
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population 826
Salivary Cystatin D Interactome in Patients with Systemic Mastocytosis: An Exploratory Study 825
A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G 823
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic. Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)H 817
Cofactors, age at onset, allergic comorbidities and gender are different in patients sensitized to omega-5 gliadin and Pru p 3 755
Aspects of hereditary angioedema genotyping in the era of NGS: The case of F12 gene = Wybrane aspekty genotypowania wrodzonego obrzȩku naczynioruchowego w erze NGS: Gen F12 744
Evaluation of Antibody Response to Heterologous Prime-Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study 737
Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic 733
Totale 186.086
Categoria #
all - tutte 262.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 262.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022.779 0 0 0 377 9.052 6.511 3.543 787 490 573 501 945
2020/202144.906 1.061 1.527 1.511 11.946 8.988 5.090 3.203 3.109 1.519 2.594 2.618 1.740
2021/202212.565 1.277 721 586 986 922 896 795 607 1.311 1.144 1.659 1.661
2022/202317.536 1.347 2.302 2.432 1.366 1.532 1.814 944 1.546 1.052 991 1.336 874
2023/202420.785 1.275 781 979 1.614 1.945 3.424 3.046 1.666 992 1.354 1.797 1.912
2024/202561.691 15.887 35.053 7.619 3.132 0 0 0 0 0 0 0 0
Totale 213.990